Bristol-Myers Squibb’s Psoriasis Drug Dazzles in Phase II Clinical Trial

Bristol-Myers Squibb’s Psoriasis Drug Dazzles in Phase II Clinical Trial

Source: 
BioSpace
snippet: 

Bristol-Myers Squibb announced that its Phase II clinical trial of BMS-986165 for moderate to severe plaque psoriasis hit its efficacy endpoints.